6,891 results
Search Results
202. Co-Delivery of Arsenotungstate Polyoxometalate and Curcumin Using Bis-Imidazolium Poly Ionic Liquid Nanocomposites for Boosting Anticancer Effects against Triple-negative Breast Cancer Cells
203. Failure to progress: breast and prostate cancer cell lines in developing targeted therapies
204. Acceptability of Four Intervention Components Supporting Medication Adherence in Women with Breast Cancer: a Process Evaluation of a Fractional Factorial Pilot Optimization Trial
205. Identification of N6-Methyladenosine-Associated lncRNAs and Analysis of Prognostic Signature in Breast Cancer
206. Enhancing Patient Outcomes Through Integrated Education and Navigation Programs at the Breast Cancer Comprehensive Center, National Cancer Institute, Cairo University
207. Identification of HOXC Gene Family as Prognostic and Immune-Related Biomarkers in Breast Cancer Through mRNA Transcriptional Profile and Experimental Validation
208. Injectable Hydrogels for Intratumoral Administration Against Breast Cancer
209. A multimodal cancer rehabilitation programme promoting sense of coherence for women treated for female reproductive cancers: a pilot randomised controlled trial
210. A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer
211. Enhanced cancer cell proliferation and aggressive phenotype counterbalance in breast cancer with high BRCA1 gene expression
212. Effects of concurrent aerobic and strength training in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis
213. miRNAs that regulate apoptosis in breast cancer and cervical cancer
214. Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women
215. Patient-reported observations on medical procedure timeliness (PROMPT) in breast cancer: a qualitative study
216. Contrast-enhanced mammography for surveillance in women with a personal history of breast cancer
217. Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study
218. Evaluation of Boric Acid Treatment on microRNA‐127‐5p and Metastasis Genes Orchestration of Breast Cancer Stem Cells
219. C-Peptide and BMi predict anti-hyperglycemic treatment lines in breast cancer patients treated with Alpelisib
220. Photothermal Depth Profiling of Gelatin-Stabilised Gold Nanorods-Trastuzumab Conjugate as a Potential Breast Cancer Photothermal Agent
221. Vision transformer based convolutional neural network for breast cancer histopathological images classification
222. The Importance of Hypoxia-Related to Hemoglobin Concentration in Breast Cancer
223. Fear of cancer recurrence and change in hair cortisol concentrations in partners of breast cancer survivors
224. Social Support, Diet, and Physical Activity among Latina/Hispanic Women Breast Cancer Survivors
225. Diabetes Driven Oncogenesis and Anticancer Potential of Repurposed Antidiabetic Drug: A Systemic Review
226. Morphofunctional Characteristics of the Vessels of the Subareolar Lymphatic Plexus in Breast Cancer with Metastasis to the Lymph Nodes of the Axillary Lymphatic Collector
227. Magnification Independent Breast Cancer Analysis Using Vision Transformer
228. Convergence of various computer-aided systems for breast tumor diagnosis: a comparative insight
229. Preparation of Dextran- and Carboxymethyl Dextran–Coated Fe3O4 Nanoparticles for Breast Cancer Cell Labeling and Magnetic Hyperthermia
230. Measuring serum oestrogen levels in breast cancer survivors using vaginal oestrogens: a systematic review
231. Risk of Malignant Neoplasm in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis
232. Prognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer: a retrospective observational study
233. Axillary Management: How Much Is Too Much?
234. An exploratory clinical trial of preoperative non-invasive localization before breast-conserving surgery using augmented reality technology
235. Clinical and molecular predictors of very late recurrence in oestrogen receptor-positive breast cancer patients
236. Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer
237. Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO
238. A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer
239. Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications
240. Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane
241. Ethnic disparities in breast cancer patterns in Brazil: examining findings from population-based registries
242. Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0 breast cancer patients: impact on axillary morbidity and survival—a propensity score cohort study
243. Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?
244. Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses’ Health Studies
245. STK3 higher expression association with clinical characteristics in intrinsic subtypes of breast cancer invasive ductal carcinoma patients
246. Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay
247. Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study
248. Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value
249. Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis
250. BRCA1/2 mutation carriers vs the general breast cancer population (N = 799,986): 21-gene assay-based molecular characterization
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.